INSIGHTS ON DRUG DEVELOPMENT
-
Automated Testing For Compound Toxicity Effects
Explore how anti-cancer drugs' toxic effects on intestinal cells limit dosages as well as how 3D organoids and assay automation can enhance drug development by improving testing processes.
-
Data-Driven Strategies To De-Risk OSD Development
Watch as Quentin Horgan, Director of Drugs Intelligence at GlobalData discusses how early-stage insights can improve development outcomes and reduce downstream risk.
-
Mitigating Early Development Risks
Discover how the efficient screening of biologic candidates accelerates the discovery process, reduces costs, and improves the likelihood of commercializing safe and effective drugs.
-
Overcoming Challenges In Ophthalmic Formulations
Discover key strategies for overcoming formulation challenges in ophthalmic drug development and learn how selecting the right excipients supports quality, compliance, and safety.
-
5 Key Considerations For Companies Outsourcing Process Development6/9/2025
Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.
-
Silencing CDMO Project Noise: The Power Of Low-Drama Drug Development3/3/2026
Move beyond reactive firefighting by prioritizing disciplined leadership and data-driven milestones. The winning model for complex programs is focused, high-maturity, low-drama execution.
-
Generate CHO-K1 GFP-Expressing Cells For Cell Line Development Workflow11/7/2025
Discover a high-efficiency workflow for generating GFP-expressing CHO-K1 clones using automated single-cell dispensing to achieve 93% isolation success and stable expression in under five weeks.
-
Bioanalytical Quantification Of A Biotherapeutic Peptide7/17/2025
Discover a sensitive, selective, and robust LC-MS method for quantifying semaglutide in plasma with advanced sample preparation and detection technologies for accurate results in bioanalytical research.
-
Accelerating Clinical Development: Modern Tools In Process Chemistry1/23/2025
Whether you aim to address bottlenecks or explore advanced techniques, gain a practical and forward-thinking perspective to streamline early-phase development with HTE and model-based approaches.
DRUG DEVELOPMENT SOLUTIONS
-
The ACQUITY Premier Solution enables your lab to make informed decisions and reduce risk with stronger analytical capabilities to detect more of your sample components from the very beginning.
-
Curia was the first CRO to provide contract medicinal chemistry services to the pharmaceutical industry.
-
Calculators & Predictors for LogP, LogD, pKa, Aqueous Solubility, and more…
The physicochemical properties of a molecule can help you better understand its likely behavior, support QSPR high-throughput screening (HTS) of libraries, and data-driven lead optimization.
ACD/PhysChem Suite is made up of a number of prediction modules. It provides high-quality, structure-based calculations of physicochemical properties.
- Predict aqueous solubility,* boiling point, logD,* logP,* pKa,* Sigma, and other molecular descriptors for organic compounds, from structure
- Evaluate the calculated results with sorting, plotting tools
- Assess the reliability of predicted physicochemical property values
- Investigate quantitative structure-property relationships, structure modifications, and/or lead optimization for a target profile
- Train predictors with experimental data to better reflect novel chemical space
- Include custom models and in-house prediction algorithms
*Models are trainable with experimental data
-
An industry-renowned instrument for monitoring GPCRs and ion channels
Powered by a new, optional high-speed EMCCD camera and the new Peak Pro 2 software module, the new FLIPR® Penta High-Throughput Cellular Screening System allows you to measure and analyze peaks of human-derived induced pluripotent stem cells (hiPSCs), differentiated into cardiomyocytes and neurons, up to 100 times per second and quickly cherry pick events such as Early Afterdepolarization-like events (EAD-like events), fibrillation, and irregular beating.
-
Eurofins offers the world’s largest network of harmonized GMP bio/pharmaceutical testing labs, delivering comprehensive, compliant, and customizable CMC services across the drug development lifecycle.